Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 17 16:05 ET
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 10 16:03 ET
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 9 16:05 ET
Clearmind Medicine | 20-F/A: Registration statement / Annual report / Transition report (Amendment)
Mar 27 16:40 ET
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 27 16:05 ET
Clearmind Medicine | EFFECT: Others
Mar 25 06:03 ET
Clearmind Medicine | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Mar 20 16:58 ET
Clearmind Medicine | 6-K: Report of foreign private issuer (related to financial reporting)
Mar 19 12:45 ET
Clearmind Medicine | 20-F/A: Registration statement / Annual report / Transition report (Amendment)
Mar 18 17:22 ET
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 13 16:05 ET
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 27 16:02 ET
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 23 16:07 ET
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 20 16:09 ET
Clearmind Medicine | EFFECT: Others
Feb 20 06:03 ET
Clearmind Medicine | CORRESP: CORRESP
Feb 14 22:21 ET
Clearmind Medicine | UPLOAD: Others
Feb 14 22:16 ET
Clearmind Medicine | SC 13G: Statement of acquisition of beneficial ownership by individuals-AdvisorShares Trust(5.48%)
Feb 14 11:12 ET
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 9 16:05 ET
Clearmind Medicine | D: Filing D
Feb 7 13:46 ET
Clearmind Medicine | F-1: Registration statement for securities of certain foreign private issuers
Feb 7 07:35 ET
No Data
No Data